These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 32822389

  • 1. Chemogenetic attenuation of neuronal activity in the entorhinal cortex reduces Aβ and tau pathology in the hippocampus.
    Rodriguez GA, Barrett GM, Duff KE, Hussaini SA.
    PLoS Biol; 2020 Aug; 18(8):e3000851. PubMed ID: 32822389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Entorhinal cortex vulnerability to human APP expression promotes hyperexcitability and tau pathology.
    Goettemoeller AM, Banks E, Kumar P, Olah VJ, McCann KE, South K, Ramelow CC, Eaton A, Duong DM, Seyfried NT, Weinshenker D, Rangaraju S, Rowan MJM.
    Nat Commun; 2024 Sep 10; 15(1):7918. PubMed ID: 39256379
    [Abstract] [Full Text] [Related]

  • 5. A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy.
    Siman R, Lin YG, Malthankar-Phatak G, Dong Y.
    J Neuropathol Exp Neurol; 2013 Nov 10; 72(11):1062-71. PubMed ID: 24128676
    [Abstract] [Full Text] [Related]

  • 6. Propagation of tau pathology in a model of early Alzheimer's disease.
    de Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, Pitstick R, Sahara N, Ashe KH, Carlson GA, Spires-Jones TL, Hyman BT.
    Neuron; 2012 Feb 23; 73(4):685-97. PubMed ID: 22365544
    [Abstract] [Full Text] [Related]

  • 7. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM, Parikh SJ, Abdul-Hay SO, Sahara T, Kang D, Dickson DW, Saftig P, LaFerla FM, Lane S, Leissring MA.
    Alzheimers Res Ther; 2024 Apr 04; 16(1):70. PubMed ID: 38575959
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.
    Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, Bien-Ly N, Bender A, Mucke L.
    J Neurosci; 2007 Mar 14; 27(11):2727-33. PubMed ID: 17360894
    [Abstract] [Full Text] [Related]

  • 10. Human P301L-mutant tau expression in mouse entorhinal-hippocampal network causes tau aggregation and presynaptic pathology but no cognitive deficits.
    Harris JA, Koyama A, Maeda S, Ho K, Devidze N, Dubal DB, Yu GQ, Masliah E, Mucke L.
    PLoS One; 2012 Mar 14; 7(9):e45881. PubMed ID: 23029293
    [Abstract] [Full Text] [Related]

  • 11. Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex.
    Welikovitch LA, Do Carmo S, Maglóczky Z, Szocsics P, Lőke J, Freund T, Cuello AC.
    Acta Neuropathol; 2018 Dec 14; 136(6):901-917. PubMed ID: 30362029
    [Abstract] [Full Text] [Related]

  • 12. Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.
    Li C, Götz J.
    EMBO J; 2017 Nov 02; 36(21):3120-3138. PubMed ID: 28864542
    [Abstract] [Full Text] [Related]

  • 13. Trans-synaptic spread of tau pathology in vivo.
    Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, Duff K.
    PLoS One; 2012 Nov 02; 7(2):e31302. PubMed ID: 22312444
    [Abstract] [Full Text] [Related]

  • 14. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE, Yao H, Beaulieu-Abdelahad D, Ait-Ghezala G, Mouzon B, Crawford F, Mullan M, Paris D.
    Acta Neuropathol Commun; 2017 Sep 06; 5(1):69. PubMed ID: 28877763
    [Abstract] [Full Text] [Related]

  • 15. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
    Seino Y, Kawarabayashi T, Wakasaya Y, Watanabe M, Takamura A, Yamamoto-Watanabe Y, Kurata T, Abe K, Ikeda M, Westaway D, Murakami T, Hyslop PS, Matsubara E, Shoji M.
    J Neurosci Res; 2010 Dec 06; 88(16):3547-54. PubMed ID: 20936700
    [Abstract] [Full Text] [Related]

  • 16. Tau Protein Mediates APP Intracellular Domain (AICD)-Induced Alzheimer's-Like Pathological Features in Mice.
    Ghosal K, Fan Q, Dawson HN, Pimplikar SW.
    PLoS One; 2016 Dec 06; 11(7):e0159435. PubMed ID: 27459671
    [Abstract] [Full Text] [Related]

  • 17. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A, Hunter J, Quadri Z, Zamudio F, Rocha-Rangel PV, Chan D, Kesarwani A, Nash K, Lee DC, Morgan D, Gordon MN, Selenica MB.
    Front Immunol; 2020 Dec 06; 11():997. PubMed ID: 32508844
    [Abstract] [Full Text] [Related]

  • 18. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
    Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, Saido TC, Ikezu S, Ikezu T.
    Mol Neurodegener; 2021 Mar 22; 16(1):18. PubMed ID: 33752701
    [Abstract] [Full Text] [Related]

  • 19. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y, Hua L, Yeh CK, Shen L, Ying M, Zhang Z, Liu G, Li S, Chen S, Chen X, Yang X.
    Theranostics; 2020 Mar 22; 10(25):11794-11819. PubMed ID: 33052247
    [Abstract] [Full Text] [Related]

  • 20. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
    Arner A, Rockenstein E, Mante M, Florio J, Masliah D, Salehi B, Adame A, Overk C, Masliah E, Rissman RA.
    J Alzheimers Dis; 2018 Mar 22; 61(3):1201-1219. PubMed ID: 29332037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.